Reference
Therapeutic Goods Administration. AstraZeneca ChAdOx1-S COVID-19 vaccine. Update - Expert review finds no evidence of increased risk of anaphylaxis. Internet Document : 19 Mar 2021. Available from: URL: https://www.tga.gov.au/alert/astrazeneca-chadox1-s-covid-19-vaccine-0
Rights and permissions
About this article
Cite this article
No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine. Reactions Weekly 1849, 3 (2021). https://doi.org/10.1007/s40278-021-93387-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-93387-2